Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Cancer Letters|September 3, 2017
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiramJuan Cong, Yangyang Wang, Xiao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancerPaul Sabbatini, Jakob Dupont, Carol Aghajanian, et al.
Journal of the National Cancer Institute|February 7, 2016
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaFrancesco Sabbatino, Yangyang Wang, Giosuè Scognamiglio, et al.
International Journal of Cancer|August 18, 2010
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinomaGiuseppe Sconocchia, Inti Zlobec, Alessandro Lugli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in MelanomaJoe-Marc Chauvin, Mignane Ka, Ornella Pagliano, et al.
Cancer Letters|February 16, 2024
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinomaGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Cancer|May 23, 2013
Pathologic and gene expression features of metastatic melanomas to the brainRonald Hamilton, Michal Krauze, Marjorie Romkes, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
The American Journal of Pathology|December 11, 2012
Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric studyIsabela J Wastowski, Renata T Simões, Layale Yaghi, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Cancer Letters|September 3, 2017
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiramJuan Cong, Yangyang Wang, Xiao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancerPaul Sabbatini, Jakob Dupont, Carol Aghajanian, et al.
Journal of the National Cancer Institute|February 7, 2016
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaFrancesco Sabbatino, Yangyang Wang, Giosuè Scognamiglio, et al.
International Journal of Cancer|August 18, 2010
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinomaGiuseppe Sconocchia, Inti Zlobec, Alessandro Lugli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2020
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in MelanomaJoe-Marc Chauvin, Mignane Ka, Ornella Pagliano, et al.
Cancer Letters|February 16, 2024
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinomaGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.
Cancer|May 23, 2013
Pathologic and gene expression features of metastatic melanomas to the brainRonald Hamilton, Michal Krauze, Marjorie Romkes, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
The American Journal of Pathology|December 11, 2012
Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric studyIsabela J Wastowski, Renata T Simões, Layale Yaghi, et al.
Pageof 34